Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma

Condition:   Nasopharyngeal Carcinoma
Interventions:   Drug: Nivolumab;   Drug: Cisplatin;   Radiation: Radiation Therapy
Sponsors:   University of California, San Francisco;   National University Cancer Institute, Singapore;   Bristol-Myers Squibb
Not yet recruiting - verified August 2017

http://ift.tt/2x4SPyT